- Home
- CLSK vs CPRX Comparison
CLSK vs CPRX Comparison
Compare CLSK & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$24.16
Company Overview
Basic Information| Metric | CLSK | CPRX |
|---|---|---|
| Founded | 1987 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2008 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CLSK | CPRX |
|---|---|---|
| Price | $9.90 | $24.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $19.69 | ★ $33.25 |
| AVG Volume (30 Days) | ★ 26.3M | 1.1M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 107.94 |
| EPS | N/A | ★ 1.27 |
| Revenue | ★ $766,314,000.00 | $119,072,803.00 |
| Revenue This Year | N/A | $19.98 |
| Revenue Next Year | $19.58 | $6.96 |
| P/E Ratio | ★ N/A | $18.93 |
| Revenue Growth | ★ 102.21 | 16.39 |
| 52 Week Low | $6.46 | $19.05 |
| 52 Week High | $23.61 | $26.56 |
Technical Indicators
Market Signals| Indicator | CLSK | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 49.91 |
| Support Level | $8.55 | $22.25 |
| Resistance Level | $10.46 | $24.63 |
| Average True Range (ATR) | 0.90 | 0.78 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 74.15 | 38.26 |
Price Performance
Historical Comparison CLSK
CPRX
About CLSK CleanSpark Inc.
Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).